Best practices in the cardiac catheterization laboratory (CCL)

SCAI publishes updated guidelines for cath lab best practices

Washington, D.C. , USA (May 2, 2016) – Today, the Society for Cardiovascular Angiography and Interventions (SCAI) published an update to its first-of-its-kind 2012 paper outlining best practices in the cardiac catheterization laboratory (CCL), or cath lab. The paper, "SCAI Expert Consensus Statement: 2016 Best Practices in the Cardiac Catheterization Laboratory," was published online in Catheterization and Cardiovascular Interventions, SCAI’s official journal.

The document provides cath labs around the country with a set of agreed-upon recommended guidelines developed by expert practicing interventional cardiologists to ensure the highest quality of care and ultimately better patient outcomes, as well as improved patient and physician satisfaction. The paper includes pre-, intra-, and post-procedure recommendations.

"SCAI created the Best Practices Guidelines in 2012 because there had been no process standardization in cath labs and labs had been working under only local regulation and policy," said Srihari S. Naidu, MD, FACC, FSCAI, FAHA, associate professor of medicine at the SUNY Stony Brook School of Medicine, director of the cardiac catheterization laboratory at Winthrop University Hospital and the paper’s lead author. "There is a tremendous appetite among interventional cardiologists for a comprehensive document outlining the details on how a cardiac cath lab should operate."

The document includes:

  • An updated pre-procedure checklist for cardiac catheterization that provides a nurse, technician, APP, physician extender, or physician with a set of questions to review with the patient.
  • Language on cath lab governance and the responsibilities of a cath lab director. Techniques are provided on how CCLs can improve function through effective governance and management strategies.
  • Information on cost consideration. Specific strategies CCLs can employ to provide the highest value of care are outlined.
  • Information on radial access. There is recent support for radial access procedures (procedures done through the wrist), which were not covered in the 2012 paper. Best practices on when radial access is appropriate and considerations CCLs should take is included.
  • New evidence on medications. Recent data includes medications brought to market after the 2012 paper and when to use certain drugs and dosage amounts.
  • Recommendations on maintaining appropriate industry relationships, for example:
      • Industry’s role in individual CCLs should be consistent with policies set by the hospital and/or director.
      • Industry should not have "hands-on" equipment in the CCL, except for defined educational purposes or device preparation.
      • Industry should always provide information and advice that is in the best interest of the patient, regardless of other considerations.
  • Techniques for enhancing patient satisfaction in the CCL including pre-, intra-, and post-procedure recommendations for improving patient satisfaction.

The paper, which cross-references other SCAI reports and documents, clearly reflects the direction in which the profession of interventional cardiology is heading.

"SCAI is a valuable organization for cardiologists to join as it lends them a voice and the opportunity to impact and influence the future of interventional cardiology," said Sunil V. Rao, MD, FSCAI, chair of SCAI’s Quality Improvement Committee, associate professor of medicine at the Duke University Medical Center and section chief of cardiology at Durham VA Medical Center.

"The guidelines reflect SCAI’s commitment and continued efforts to improve quality of care and the patient experience," said SCAI President James C. Blankenship, MD, MHCM, FSCAI, MACC, practicing interventional cardiologist at Geisinger Medical Center in Danville, Pa., and director of the Geisinger cardiology department and catheterization laboratories.

About SCAI

The Society for Cardiovascular Angiography and Interventions is a 4,500-member professional organization representing invasive and interventional cardiologists in approximately 70 nations. SCAI’s mission is to promote excellence in invasive/interventional cardiovascular medicine through physician education and representation, and advancement of quality standards to enhance patient care. SCAI’s public education program, Seconds Count, offers comprehensive information about cardiovascular disease. For more information about SCAI and Seconds Count, visit http://www.SCAI.org or http://www.SecondsCount.org . Follow @SCAI on Twitter for the latest heart health news.


Society for Cardiovascular Angiography and Interventions , 02.05.2016 (tB).

MEDICAL NEWS

After old age, intellectual disability is greatest risk factor for…
New Corona test developed
Smoking cessation drug may treat Parkinson’s in women
Meeting highlights from the Committee for Medicinal Products for Human…
Using face masks in the community: first update – Effectiveness…

SCHMERZ PAINCARE

Projekt PAIN2020: Wir nehmen Schmerzen frühzeitig ernst. Jetzt für alle…
Wechselwirkung zwischen psychischen Störungen und Schmerzerkrankungen besser verstehen
Lisa Olstein: Weh – Über den Schmerz und das Leben
Wie ein Schmerz den anderen unterdrückt
Opioidtherapien im palliativen Praxisalltag: Retardierte Analgetika zeigen Vorteile

DIABETES

Kinder und Jugendliche mit Typ-1-Diabetes gehören nicht zur Risikogruppe und…
Neue Studie will Entstehung von Typ-1-Diabetes bei Kindern verhindern
Toujeo®: Ein Beitrag zu mehr Sicherheit für Menschen mit Typ-1-Diabetes
Diabetes: Neue Entdeckung könnte die Behandlung künftig verändern
Für Menschen mit Typ-2-Diabetes: Fixkombination aus Basalinsulin und GLP-1-Analogon

ERNÄHRUNG

Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?
Regelmässiger Koffeinkonsum verändert Hirnstrukturen
Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren
Gesundheitliche Auswirkungen des Salzkonsums bleiben unklar: Weder der Nutzen noch…
Fast Food, Bio-Lebensmittel, Energydrinks: neue Daten zum Ernährungsverhalten in Deutschland

ONKOLOGIE

Krebsüberleben hängt von der Adresse ab
Vitamin D-Supplementierung: möglicher Gewinn an Lebensjahren bei gleichzeitiger Kostenersparnis
Konferenzbericht: Aktuelle Daten aus der Hämatologie vom ASH 2020
Anzeige: Aktuelle Daten zur Therapie des fortgeschrittenen Prostatakarzinoms
Aktuelle Daten zu Apalutamid und Abirateron in der Therapie des…

MULTIPLE SKLEROSE

Erste tierexperimentelle Daten zur mRNA-Impfung gegen Multiple Sklerose
Multiple Sklerose: Immuntherapie erhöht nicht das Risiko für schweren COVID-19-Verlauf
Empfehlung zur Corona-Impfung bei Multipler Sklerose (MS)
Fallstudie: Beeinflusst SARS-CoV-2 Infektion die Multiple Sklerose?
Multiple Sklerose: Novartis’ Siponimod verzögert Krankheitsprogression und Hirnatrophie bei aktiver…

PARKINSON

Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…
Gemeinsam gegen Parkinson: bessere Therapie durch multidisziplinäre Versorgung
Neuer Bewegungsratgeber unterstützt Menschen mit M. Parkinson durch Yoga
Covid-19-Prävention: besondere Vorsicht bei Patienten mit der Parkinson-Krankheit
Neue Studie zur tiefen Hirnstimulation bei Parkinson-Erkrankung als Meilenstein der…